CRDF Historical Earnings image   This CRDF historical earnings page last updated 5/9/2022
CRDF Historical Revenue
PeriodHistorical Earnings DateGAAP
Q1 20225/5/20220.07M
Q4 20212/24/20220.00B
Q3 202111/4/20210.09M
Q2 20218/5/20210.07M
Q1 20215/6/20210.07M
Q4 20202/25/20210.00B
Q3 202011/5/20200.00B
Q2 20208/11/20200.04M
Q1 20205/7/20200.07M
Q4 20192/27/20200.09M
Q3 201911/7/20190.05M
Q2 20198/8/20190.00B
Q1 20195/7/20190.00B
Q4 20183/6/201978000
Q3 201811/7/201888000
Q2 20188/3/2018112000
Q1 20185/8/2018100000
Q4 20172/26/2018185000
Q3 201711/9/2017123000
Q2 20178/9/2017102000
Q1 20175/10/201795000
Q4 20163/15/201768000
Q3 201611/9/201689000
Q2 20168/4/2016104000
Q1 20165/10/2016120000
Q4 20153/10/201679000
Q3 201511/9/201557000
Q2 20158/10/201550000
Q1 20155/5/2015127000
Q4 20143/12/201556000
Q3 201411/6/201457000
Q2 20148/7/201456000
Q1 20145/12/2014111000
Q4 20133/17/201447000
Q3 201311/14/201344000
Q2 20138/14/201349000
CRDF Historical Earnings EPS
Data adjusted for CRDF split history

PeriodHistorical Earnings DateGAAP
Q1 20225/5/2022-0.250
Q4 20212/24/2022-0.230
Q3 202111/4/2021-0.170
Q2 20218/5/2021-0.170
Q1 20215/6/2021-0.140
Q4 20202/25/2021-0.190
Q3 202011/5/2020-0.190
Q2 20208/11/2020-0.510
Q1 20205/7/2020-0.410
Q4 20192/27/2020-0.510
Q3 201911/7/2019-0.710
Q2 20198/8/2019-0.790
Q1 20195/7/2019-1.020
Q4 20183/6/2019-1.09
Q3 201811/7/2018-0.18
Q2 20188/3/2018-0.44
Q1 20185/8/2018-0.09
Q4 20172/26/2018-0.06
Q3 201711/9/2017-0.12
Q2 20178/9/2017-0.14
Q1 20175/10/2017-0.32
Q4 20163/15/2017-0.25
Q3 201611/9/2016-0.34
Q2 20168/4/2016-0.34
Q1 20165/10/2016-0.36
Q4 20153/10/2016-0.26
Q3 201511/9/2015-0.23
Q2 20158/10/2015-0.41
Q1 20155/5/2015-0.24
Q4 20143/12/2015-0.25
Q3 201411/6/2014-0.28
Q2 20148/7/2014-0.06
Q1 20145/12/2014-0.17
Q4 20133/17/2014-0.05
Q3 201311/14/2013-0.25
Q2 20138/14/2013-0.3
Quotes delayed 20 minutes

Email EnvelopeFree CRDF Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Cardiff Oncology (CRDF) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

CRIS Past Earnings
CRL Past Earnings
CRMD Past Earnings
CRNX Past Earnings
CRTX Past Earnings
CRVL Past Earnings
CRVS Past Earnings
CRY Past Earnings
CSBR Past Earnings
CSII Past Earnings
What was the record high CRDF historical earnings result?
In terms of earnings or revenue, what is the best CRDF historical earnings result that Cardiff Oncology has ever posted, and when?

✔️Accepted answer: Within our data set, the highest CRDF historical earnings result was set in Q4 2013, when Cardiff Oncology posted results of -0.05/share. The most successful revenue quarter within our data set was Q4 2017 when Cardiff Oncology reported revenue of 185000.

What was the lowest Cardiff Oncology historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest CRDF has reported, and when?

✔️Accepted answer: Within our data set, the lowest CRDF historical earnings result was set in Q4 2018, when Cardiff Oncology posted results of -1.09/share. The smallest revenue quarter within our data set was Q2 2020 when Cardiff Oncology reported revenue of 0.04M.

On this page we presented the CRDF historical earnings date information for Cardiff Oncology. Reviewing that CRDF Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2013, when CRDF posted gaap of -0.05/share. Meanwhile the lowest CRDF historical earnings result was in Q4 2018, when CRDF posted gaap of -1.09/share. Moving to Cardiff Oncologys historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2017 when CRDF reported 185000 in revenue, while the smallest revenue quarter was Q2 2020 when CRDF reported 0.04M in revenue.

For self directed investors doing their due diligence on CRDF or any other given stock, their research can benefit from looking into all of the Cardiff Oncology historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Cardiff Oncology historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for CRDF. Thanks for visiting, and the next time you need to research CRDF historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Institutional Holders of PNTG, Funds Holding MCRL, Institutional Holders of AT.

 

CRDF Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.